Katharine Peterson - Chief Accounting Officer at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
ACRV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Katharine Peterson since 12/22/2023

Holdings reported by Katharine Peterson for Acrivon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.54K $35.9K $7.92 Nov 14, 2024 Direct

Transactions reported by Katharine Peterson for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.